en.Wedoany.com Reported - Channel Robotics announced the completion of a $2.5 million Seed+ round led by True Ventures, as the company develops the first handheld AI endoscopic robotic platform. This round brings the company's total funding to $4.6 million, which will be used for product development, regulatory advancement, and commercialization preparation.
Headquartered in San Diego, California, Channel Robotics is a medical technology company dedicated to developing the first handheld endoscopic robotic platform. The patented technology aims to provide robotic-level dexterity through existing flexible endoscopes without the need for large, capital-intensive robotic systems, targeting expanded access to advanced endoscopic procedures in hospitals, ambulatory surgery centers, and community clinics.
The Seed+ round follows the company's $2.1 million Seed round, which included participation from Defined VC and Old Line Capital Partners. The current round brings together investors with expertise in healthcare, medical technology, and company building, with True Ventures known for supporting transformative technology companies, while Defined Ventures and Old Line Capital Partners specialize in supporting healthcare innovation and long-term company growth.
Dr. Michael Yip, co-founder of Channel Robotics, stated that the company's mission is to democratize advanced endoscopic robotics technology, and this funding enables them to continue building a practical, scalable, and cost-effective platform that provides physicians with advanced robotic capabilities.
This funding will support several key milestones, including continued optimization and validation of the prototype platform, expansion of engineering and product development efforts, preparation for submission to the U.S. Food and Drug Administration (FDA) in 2027, advancement of manufacturing and quality system development, and preparation for commercial launch following regulatory clearance.
Rohit Sharma, partner at True Ventures, noted that Mike and Philip represent a rare combination of deep clinical experience and robotics expertise, capable of delivering practical solutions to more clinics and physicians, with their innovation addressing robotic challenges in human health services.
Dr. Philip Weissbrod, co-founder and CEO of Channel Robotics, stated that with support from True Ventures and existing investors, the company is well-positioned to accelerate development and bring the technology to clinicians and patients, adding that the future of endoscopic robotics will be defined by solutions that are more accessible, easier to adopt, and capable of reaching more patients.
Channel Robotics is a San Diego, California-based medical technology company founded by physician-scientist Dr. Philip Weissbrod and robotics expert Dr. Michael Yip, developing the next-generation endoscopic robotic platform that combines novel robotic instruments, intuitive control systems, and artificial intelligence to enable more precise and accessible endoscopic interventions.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
